|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.068 SEK | -2.27% |
|
-3.63% | -50.59% |
| 06-26 | Cantargia: Study Bolsters IL1RAP as a Target in Pancreatic Cancer | FW |
| 06-26 | Cantargia Announces Publication Of Data Supporting IL1RAP As A Therapeutic Target And Predictive Biomarker In PDAC | CI |
| Market Cap | 514M 53.16M 46.52M 42.88M 39.74M 75.44M 5.05B 76.66M 200M 2.49B 200M 195M 8.61B | P/E 2026 * |
-2.69x | P/E 2027 * | -2.43x |
|---|---|---|---|---|---|
| Enterprise Value | 514M 53.16M 46.52M 42.88M 39.74M 75.44M 5.05B 76.66M 200M 2.49B 200M 195M 8.61B | EV / Sales 2026 * |
490x | EV / Sales 2027 * | 13.4x |
| Free-Float |
83.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cantargia AB
| 1 day | -2.27% | ||
| 1 week | -3.63% | ||
| Current month | -3.63% | ||
| 1 month | +1.08% | ||
| 3 months | -47.41% | ||
| 6 months | -53.84% | ||
| Current year | -50.59% |
| 1 week | 2.02 |  | 2.21 |
| 1 month | 1.86 | | 2.3 |
| Current year | 1.86 | | 6.59 |
| 1 year | 1.13 | | 6.59 |
| 3 years | 1 | | 6.59 |
| 5 years | 1 | | 27.92 |
| 10 years | 1 | | 71.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 2025-08-31 | |
Patrik Renblad
DFI | Director of Finance/CFO | 56 | 2023-06-14 |
Wolfram Dempke
CTO | Chief Tech/Sci/R&D Officer | - | 2025-10-01 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 2015-12-31 | |
| Director/Board Member | 55 | 2017-12-31 | |
Flavia Borellini
BRD | Director/Board Member | 66 | 2020-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-25 | Buy | Director | 14,012 | 0.0056% | ||
| 06-25 | Buy | Director | 63,054 | 0.0254% | ||
| 06-24 | Buy | 4,444 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.27% | -3.63% | +58.83% | -46.51% | 54.48M | |
| -0.10% | +0.10% | +74.33% | +133.26% | 57.73B | |
| -3.80% | -6.24% | +67.04% | +86.36% | 54.69B | |
| +1.17% | +5.83% | +16.39% | +468.18% | 24.18B | |
| +0.38% | +1.33% | -14.32% | -11.76% | 23.75B | |
| -0.76% | +5.66% | +45.95% | -3.28% | 19.82B | |
| +3.78% | +5.65% | +44.99% | -26.23% | 17.14B | |
| +3.46% | +17.72% | +206.66% | +364.07% | 16.75B | |
| -6.42% | +10.64% | +36.95% | - | 15.57B | |
| +2.79% | +4.91% | +29.26% | +195.60% | 13.96B | |
| Average | -0.13% | +4.62% | +56.61% | +128.85% | 24.36B | |
| Weighted average by Cap. | -0.50% | +2.61% | +58.06% | +139.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.05M 109K 95.02K 87.57K 81.16K 154K 10.3M 157K 408K 5.09M 408K 399K 17.58M | 38.35M 3.97M 3.47M 3.2M 2.96M 5.63M 376M 5.72M 14.91M 186M 14.89M 14.57M 642M |
| Net income | -179M -18.54M -16.22M -14.95M -13.86M -26.3M -1.76B -26.73M -69.71M -868M -69.59M -68.08M -3B | -180M -18.58M -16.26M -14.98M -13.89M -26.36M -1.76B -26.79M -69.86M -870M -69.74M -68.23M -3.01B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | SEK 2.068 | -2.27% | 975,026 |
| 26-07-06 | SEK 2.116 | -3.20% | 249,722 |
| 26-07-03 | SEK 2.186 | +0.74% | 381,071 |
| 26-07-02 | SEK 2.170 | +3.14% | 702,720 |
| 26-07-01 | SEK 2.104 | -1.96% | 298,134 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CANTA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
